ArticleLeukemia2008

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.

C Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.